|
1
|
Chang YF, Chao A, Shih PY, Hsu YC, Lee CT,
Tien YW, Yeh YC and Chen LW: NTUH Center of Microcirculation
Medical Research (NCMMR). Comparison of dexmedetomidine versus
propofol on hemodynamics in surgical critically ill patients. J
Surg Res. 228:194–200. 2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Tan JA and Ho KM: Use of dexmedetomidine
as a sedative and analgesic agent in critically ill adult patients:
A meta-analysis. Intensive Care Med. 36:926–939. 2010.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Memiş D, Hekimoğlu S, Vatan I, Yandim T,
Yüksel M and Süt N: Effects of midazolam and dexmedetomidine on
inflammatory responses and gastric intramucosal pH to sepsis, in
critically ill patients. Br J Anaesth. 98:550–552. 2007.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Shehabi Y, Nakae H, Hammond N, Bass F,
Nicholson L and Chen J: The effect of dexmedetomidine on agitation
during weaning of mechanical ventilation in critically ill
patients. Anaesth Intensive Care. 38:82–90. 2010.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Gerlach AT, Dasta JF, Steinberg S, Martin
LC and Cook CH: A new dosing protocol reduces
dexmedetomidine-associated hypotension in critically ill surgical
patients. J Crit Care. 24(568)2009.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Iirola T, Aantaa R, Laitio R, Kentala E,
Lahtinen M, Wighton A, Garratt C, Ahtola-Sätilä T and Olkkola KT:
Pharmacokinetics of prolonged infusion of high-dose dexmedetomidine
in critically ill patients. Crit Care. 15(R257)2011.PubMed/NCBI View
Article : Google Scholar
|
|
7
|
Gupta P, Whiteside W, Sabati A, Tesoro TM,
Gossett JM, Tobias JD and Roth SJ: Safety and efficacy of prolonged
dexmedetomidine use in critically ill children with heart disease*.
Pediatr Crit Care Med. 13(660)2012.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Guinter JR and Kristeller JL: Prolonged
infusions of dexmedetomidine in critically ill patients. Am J
Health Syst Pharm. 67:1246–1253. 2010.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Burbano NH, Otero AV, Berry DE, Orr RA and
Munoz RA: Discontinuation of prolonged infusions of dexmedetomidine
in critically ill children with heart disease. Intensive Care Med.
38:300–307. 2012.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Lin H, Faraklas I, Sampson C, Saffle JR
and Cochran Al: Use of dexmedetomidine for sedation in critically
ill mechanically ventilated pediatric burn patients. J Burn Care
Res. 32(98)2008.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Demuro JP, Botros DG, Wirkowski E and
Hanna AF: Use of dexmedetomidine for the treatment of alcohol
withdrawal syndrome in critically ill patients: A retrospective
case series. J Anesth. 26:601–605. 2012.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Kress JP, O'Connor MF, Pohlman AS, Olson
D, Lavoie A, Toledano A and Hall JB: Sedation of critically ill
patients during mechanical ventilation. A comparison of propofol
and midazolam. Am J Respir Crit Care Med. 153:1012–1018.
1996.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Shelly MP, Mendel L and Park GR: Failure
of critically ill patients to metabolise midazolam. Anaesthesia.
42:619–626. 1987.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Barrientos-Vega R, Mar Sánchez-Soria M,
Morales-García C, Robas-Gómez A, Cuena-Boy R and Ayensa-Rincon A:
Prolonged sedation of critically ill patients with midazolam or
propofol: Impact on weaning and costs. Crit Care Med. 25:33–40.
1997.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Alexopoulou C, Kondili E, Diamantaki E,
Psarologakis C, Kokkini S, Bolaki M and Georgopoulos D: Effects of
dexmedetomidine on sleep quality in Critically Ill patients: A
pilot study. Anesthesiology. 121:801–807. 2014.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Benedict N, Felbinger M, Ridenour T,
Anthes A, Altawalbeh S and Kane-Gill S: Correlation of
patient-reported outcomes of sedation and sedation assessment
scores in critically ill patients. J Crit Care. 29:1132.e5–e9.
2014.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Ludtke KA, Stanley KS, Yount NL and Gerkin
RD: Retrospective review of Critically Ill patients experiencing
alcohol withdrawal: Dexmedetomidine versus propofol and/or
lorazepam continuous infusions. Hosp Pharm. 50:208–213.
2015.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Memiş D, Dökmeci D, Karamanlioğlu B, Turan
A and Türe M: A comparison of the effect on gastric emptying of
propofol or dexmedetomidine in critically ill patients: Preliminary
study. Eur J Anaesthesiol. 23:700–704. 2006.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Riker RR, Shehabi Y, Bokesch PM, Ceraso D,
Wisemandle W, Koura F, Whitten P, Margolis BD, Byrne DW, Ely EW, et
al: Dexmedetomidine vs midazolam for sedation of critically Ill
patients: A randomized trial. JAMA. 301:489–499. 2009.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Shehabi Y, Ruettimann U, Adamson H, Innes
R and Ickeringill M: Dexmedetomidine infusion for more than 24
hours in critically ill patients: Sedative and cardiovascular
effects. Intensive Care Med. 30:2188–2196. 2004.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Xu F, Wang Q, Chen S, Ao H and Ma J: The
association between intraoperative dexmedetomidine and 1 year
morbidity and mortality after cardiac surgery: A propensity matched
analysis of over 1400 patients. J Clin Anesth. 50:70–75.
2018.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Xue Y, Yuan H and Chen Y: Effects of
dexmedetomidine as an adjunct in transversus abdominis plane block
during gynecological laparoscopy. Exp Ther Med. 16:1131–1136.
2018.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Hughes J, Gill A, Leach HJ, Nunn AJ,
Billingham I, Ratcliffe J, Thornington R and Choonara I: A
prospective study of the adverse effects of midazolam on withdrawal
in critically ill children. Acta Pædiatr. 83:1194–1199.
1994.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Spina SP and Ensom MH: Clinical
pharmacokinetic monitoring of midazolam in critically ill patients.
Pharmacotherapy. 27:389–398. 2007.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Mccollam JS, O'Neil MG, Norcross ED, Byrne
TK and Reeves ST: Continuous infusions of lorazepam, midazolam, and
propofol for sedation of the critically ill surgery trauma patient:
A prospective, randomized comparison. Crit Care Med. 27:2454–2458.
1999.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Jacqz-Aigrain E, Daoud P, Burtin P,
Maherzi S and Beaufils F: Pharmacokinetics of midazolam during
continuous infusion in critically ill neonates. Eur J Clin
Pharmacol. 42:329–332. 1992.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Shafer A, Doze VA and White PF:
Pharmacokinetic variability of midazolam infusions in critically
ill patients. Crit Care Med. 18:1039–1041. 1990.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Swart EL, Zuideveld KP, de Jongh J, Danhof
M, Thijs LG and Strack van Schijndel RM: Comparative population
pharmacokinetics of lorazepam and midazolam during long-term
continuous infusion in critically ill patients. Br J Clin
Pharmacol. 57:135–145. 2004.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Dirksen MS, Vree TB and Driessen JJ:
Clinical pharmacokinetics of long-term infusion of midazolam in
critically ill patients-preliminary results. Anaesth Intensive
Care. 15:440–444. 1987.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Kirwan CJ, MacPhee IA, Lee T, Holt DW and
Philips BJ: Acute kidney injury reduces the hepatic metabolism of
midazolam in critically ill patients. Intensive Care Med. 38:76–84.
2012.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Ma C: Effect of dexmedetomidine on
postoperative delirium in elderly patients with severe diseases.
Chin J Geriatr. 34:141–143. 2015.
|
|
32
|
Romagnoli S, Amigoni A, Blangetti I,
Casella G, Chelazzi C, Forfori F, Garisto C, Mondardini MC,
Moltrasio M, Pasero D, et al: Light sedation with dexmedetomidine:
A practical approach for the intensivist in different ICU patients.
Minerva Anestesiol. 84:731–746. 2018.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Yao Y-Q and Dong-Xin W: The effect of
dexmedetomidine on the incidence of postoperative delirium in
critically ill elderly patients. J Clin Anesthesiol, 2012.
|
